Edition:
United States

Onconova Therapeutics Inc (ONTX.OQ)

ONTX.OQ on NASDAQ Stock Exchange Capital Market

3.30USD
15 Feb 2019
Change (% chg)

$0.10 (+3.12%)
Prev Close
$3.20
Open
$3.24
Day's High
$3.49
Day's Low
$3.20
Volume
16,020
Avg. Vol
25,352
52-wk High
$20.85
52-wk Low
$1.71

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.12 -0.943
Jun '18 0.49 -1.102
Mar '18 0.56 -5.043
FY 2017 Dec '17 0.14 -9.166
Sep '17 0.11 -10.599
Jun '17 0.32 -4.307
Mar '17 0.21 -18.476
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 3 4.05 8.50 1.15 3.52
Earnings (per share)
Year Ending Dec-19 4 -3.02 -2.24 -4.00 -28.20
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.48 33.70
P/E High - Last 5 Yrs. -- 44.98 49.87
P/E Low - Last 5 Yrs. -- 23.63 24.25
Beta 0.14 0.90 0.90
Price to Sales (TTM) 7.31 4.12 6.29
Price to Book (MRQ) -- 5.10 5.26
Price to Tangible Book (MRQ) -- 5.85 6.77
Price to Cash Flow (TTM) -- 24.01 24.98
% Owned Institutions 26.87 0.90 1.69

Dividends

  Company industry sector
Dividend Yield -- 1.49 1.40
Dividend Yield - 5 Year Avg -- 1.51 1.42
Dividend 5 Year Growth Rate -- 4.15 4.85
Payout Ratio(TTM) -- 43.91 41.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -85.59 4.31 12.75
Sales (TTM) vs TTM 1 Yr. Ago -84.22 4.07 5.84
Sales - 5 Yr. Growth Rate 30.12 10.91 11.23
EPS (MRQ) vs Qtr. 1 Yr. Ago 85.38 44.94 47.15
EPS (TTM) vs TTM 1 Yr. Ago 21.60 -- --
EPS - 5 Yr. Growth Rate -- 10.31 10.85
Capital Spending - 5 Yr. Growth Rate -- 15.88 15.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.25
Current Ratio (MRQ) 1.62 2.97 3.08
LT Debt to Equity (MRQ) -- 8.84 11.38
Total Debt to Equity (MRQ) -- 12.89 16.12
Interest Coverage (TTM) -- 33.79 29.47

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 53.68 53.81
Gross Margin - 5 Yr. Avg. -- 51.67 52.18
EBITD Margin (TTM) -998.77 -- --
EBITD - 5 Yr. Avg -282.89 17.96 12.87
Operating Margin (TTM) -1,002.80 14.31 6.20
Operating Margin - 5 Yr. Avg. -285.00 14.24 8.31
Pre-Tax Margin (TTM) -761.54 14.85 7.16
Pre-Tax Margin - 5 Yr. Avg. -290.16 14.68 8.61
Net Profit Margin (TTM) -762.13 11.08 3.30
Net Profit Margin - 5 Yr. Avg. -290.86 11.02 4.89
Effective Tax Rate (TTM) -- 23.02 22.91
Effective Tax Rate - 5 Yr. Avg. -- 23.16 23.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 102,522 957,645,487 842,398,385
Net Income/Employee (TTM) -781,348 113,564,537 99,842,801
Receivable Turnover (TTM) 1.98 5.71 5.71
Inventory Turnover (TTM) -- 2.61 3.47
Asset Turnover (TTM) 0.15 0.97 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -111.27 11.52 11.06
Return on Assets - 5 Yr. Avg. -73.07 12.92 12.20
Return on Investment (TTM) -307.64 14.95 14.45
Return on Investment - 5 Yr. Avg. -96.91 16.84 15.87
Return on Equity (TTM) -4,335.58 16.27 15.96
Return on Equity - 5 Yr. Avg. -- 17.77 17.00
  1 Year 3 Year 5 Year
Sales % -51.59 5.28 30.12
EPS (TTM) % 57.87 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Onconova Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 7.36 3.66 72 22
13 Week -18.60 -22.57 16 39
26 Week -36.86 -41.66 10 33
52 Week -38.60 -47.96 13 9
YTD -22.91 -32.30 19 26
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 61.50%
# of Holders: 25
Total Shares Held: 3,489,727
3 Mo. Net Change: 420,757
# New Positions: 7
# Closed Positions: 6
# Increased Positions: 8
# Reduced Positions: 12
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.